ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2188

The Association of Plasma Fatty Acids Levels with Hand and Knee Osteoarthritis

Marieke Loef1, Andreea Ioan-Facsinay 1, Dennis O Mook-Kanamori 2, Ko Willems van Dijk 1, Renée de Mutsert 1, Margreet Kloppenburg 1 and Frits R Rosendaal 1, 1Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: hand, Knee, lipids and fatty acids, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Obesity is one of the most important risk factors for osteoarthritis, and is strongly associated with increased levels of circulating fatty acids, which may result in lipotoxicity. However, our knowledge about the effect of different fatty acids on osteoarthritis is sparse. Therefore we aimed to investigate the association of plasma saturated fatty acids (SFAs), monounsaturated fatty acid (MUFAs), polyunsaturated fatty acids (PUFAs), omega-3 and omega-6 PUFAs with clinically defined hand and knee osteoarthritis.

Methods: In the population-based Netherlands Epidemiology of Obesity study, hand and knee osteoarthritis were defined by the ACR clinical classification criteria. Clinical hand and knee OA were defined by the ACR clinical classification criteria. Hand OA, knee OA and concurrent hand and knee OA were defined in 7%, 10% and 4% of participants, respectively. Plasma was sampled fasted and after a standardized meal (containing 600kCal, with 16% of energy (En%) derived from protein, 50 En% from carbohydrates and 34 En% from fat), and subsequently analysed using a nuclear magnetic resonance metabolomics platform. Since we are in a postprandial state most of the day, the postprandial samples were used for the primary analyses. All fatty acid concentrations were standardized (mean 0, SD 1). We excluded participants who reported to have inflammatory rheumatic disease or fibromyalgia, with missing physical examination, who were non-fasting at baseline, or reported using lipid-lowering medication. Logistic regression analyses were used to investigate the association between total fatty acids, SFAs, MUFAs, PUFAs, omega-6 PUFAs and omega-3 PUFAs and clinical osteoarthritis phenotypes. All analyses were stratified by sex and corrected for age, education, ethnicity and total body fat percentage.

Results: In the current analysis 5,328 NEO participants were included, with a mean age of 56 years and 58% were women (table 1). Unstratified analyses showed positive associations with OR (95% CI) of total PUFA concentrations 1.21 (1.02; 1.42), omega-3 1.17 (0.99; 1.38) and omega-6 PUFA concentrations 1.19 (1.01; 1.40) with clinical hand OA, but not with clinical knee OA. In men, total fatty acids 1.24 (1.01; 1.53), SFA 1.23 (1.00 – 1.50), total PUFA 1.26 (1.00 – 1.58) and omega‑3 PUFA levels 1.24 (1.01 – 1.52) were positively associated with clinical hand OA. Similar effect estimates were observed with concurrent hand and knee OA, but not for clinical knee OA alone. In women no associations were seen of any of the fatty acids with clinical hand or knee OA (table 2).

Conclusion: Quantitively measured plasma postprandial SFA and PUFA levels were significantly associated with hand OA in men. Intriguingly, although SFA and omega-3 PUFAs are deemed to have opposing effects on inflammation, both were positively associated with hand OA. Future research is warranted for replication and to determine whether there is a causal role for plasma fatty acid levels in hand OA.


Disclosure: M. Loef, Innovative Medicines Initiative Joint Undertaking, 2; A. Ioan-Facsinay, None; D. Mook-Kanamori, Metabolome, 5; K. Willems van Dijk, None; R. de Mutsert, None; M. Kloppenburg, AbbVie, 5, APPROACH-IMI, 2, Dutch Arthritis Foundation, 2, Dutch Arthritis Society, 2, GSK, 5, Levicept, 5, Merck-Serono, 5, Pfizer, 2, 5; F. Rosendaal, None.

To cite this abstract in AMA style:

Loef M, Ioan-Facsinay A, Mook-Kanamori D, Willems van Dijk K, de Mutsert R, Kloppenburg M, Rosendaal F. The Association of Plasma Fatty Acids Levels with Hand and Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-association-of-plasma-fatty-acids-levels-with-hand-and-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-of-plasma-fatty-acids-levels-with-hand-and-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology